Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
Clinical trial NCT00977470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00977470
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.